Literature DB >> 24226999

Drug development: Chemical brace.

Megan Cully.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24226999     DOI： 10.1038/503S10a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

Review 1.  Nogo-A represses anatomical and synaptic plasticity in the central nervous system.

Authors:  Anissa Kempf; Martin E Schwab
Journal:  Physiology (Bethesda)       Date:  2013-05

2.  Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.

Authors:  Steven Casha; David Zygun; M Dan McGowan; Ish Bains; V Wee Yong; R John Hurlbert
Journal:  Brain       Date:  2012-04       Impact factor: 13.501

3.  Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation.

Authors:  Guillermo García-Alías; Stanley Barkhuysen; Miranda Buckle; James W Fawcett
Journal:  Nat Neurosci       Date:  2009-08-09       Impact factor: 24.884

4.  A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury.

Authors:  Michael G Fehlings; Nicholas Theodore; James Harrop; Gilles Maurais; Charles Kuntz; Chris I Shaffrey; Brian K Kwon; Jens Chapman; Albert Yee; Allyson Tighe; Lisa McKerracher
Journal:  J Neurotrauma       Date:  2011-05       Impact factor: 5.269

5.  Methods to quantify pharmacologically induced alterations in motor function in human incomplete SCI.

Authors:  Christopher K Thompson; Arun Jayaraman; Catherine Kinnaird; T George Hornby
Journal:  J Vis Exp       Date:  2011-04-18       Impact factor: 1.355
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.